CSIMarket
 


Accelerate Diagnostics Inc   (AXDX)
Other Ticker:  
 
 

Accelerate Diagnostics Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Accelerate Diagnostics Inc 's ability to collect accounts receivable sequentially worsen to 3.94, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Accelerate Diagnostics Inc 's Average receivable collection period in the Sep 30 2023 quarter, has increased to 93 days, from 76 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 448 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 2877 to 2930.

What is Receivable Turnover Ratio?
What is Accelerate Diagnostics Inc Selling?


What is Receivable Turnover Ratio?




AXDX Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change 11.41 % -20.2 % 14.81 % 4.14 % 5.46 %
Y / Y Revenue Change -62.6 % -27.51 % -4.94 % -62.1 % -5.19 %
Receivable Turnover Ratio (TTM) 3.94 4.82 4.96 5.17 7.22
AXDX's Total Ranking # 2930 # 2877 # 2775 # 2983 # 2267
Average receivable collection period 93 76 74 71 51
Seq. Receivable Change 13.83 % -3.5 % 0.46 % 0.96 % -18.47 %
Seq. Revenue Change -60.45 % -0.46 % -5.42 % 0.44 % -23.34 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 449
Overall Market # 2930

Receivable Turnover Ratio Statistics
High Average Low
0.24 0.07 0
(Sep 30 2022)   (Sep. 30, 2014)






Financial Statements
Accelerate Diagnostics Inc 's Accounts Receivable $ 3 Millions Visit AXDX's Balance sheet
Accelerate Diagnostics Inc 's Sales TTM $ 10 Millions Visit AXDX's Income Statement
Where are AXDX's Sales coming from? Visit AXDX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AXDX's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for AXDX's Competitors
Receivables Turnover Ratio for AXDX's Suppliers
Accounts Receivables Turnover Ratio for AXDX's Customers

You may also want to know
AXDX's Growth Rates AXDX's Roa AXDX's Inventory Turnover Ratio AXDX's Dividend Comparisons
AXDX's Profitability Ratios AXDX's Roi AXDX's Asset Turnover Ratio AXDX's Dividend Growth
AXDX's Valuation Ratios AXDX's Roe AXDX's Financial Strength Ratios AXDX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Neurometrix Inc   9.95 $ 6.431  Millions$ 0.646  Millions
United Therapeutics Corporation  9.95 $ 2,204.300  Millions$ 221.550  Millions
Viemed Healthcare Inc   9.90 $ 169.777  Millions$ 17.143  Millions
Intercept Pharmaceuticals inc   9.78 $ 288.248  Millions$ 29.470  Millions
Editas Medicine Inc   9.75 $ 24.611  Millions$ 2.524  Millions
Quidelortho Corp  9.56 $ 3,121.741  Millions$ 326.650  Millions
The Pennant Group Inc   9.49 $ 523.602  Millions$ 55.171  Millions
Femasys Inc   9.49 $ 1.093  Millions$ 0.115  Millions
Avalon Globocare Corp   9.45 $ 1.231  Millions$ 0.130  Millions
Scientific Industries Inc   9.41 $ 11.043  Millions$ 1.174  Millions
Irhythm Technologies Inc   9.40 $ 471.752  Millions$ 50.163  Millions
Ngm Biopharmaceuticals Inc   9.37 $ 22.433  Millions$ 2.393  Millions
Biolase Inc   9.36 $ 49.382  Millions$ 5.276  Millions
Procyon Corporation  9.24 $ 4.684  Millions$ 0.507  Millions
Cara Therapeutics inc   9.20 $ 21.225  Millions$ 2.308  Millions
Acorda Therapeutics Inc   9.18 $ 111.118  Millions$ 12.106  Millions
Harmony Biosciences Holdings inc   9.09 $ 541.622  Millions$ 59.598  Millions
Myomo Inc   9.08 $ 17.258  Millions$ 1.901  Millions
Talis Biomedical Corporation  9.04 $ 2.196  Millions$ 0.243  Millions
Avid Bioservices Inc   8.95 $ 140.252  Millions$ 15.678  Millions
Emmaus Life Sciences Inc   8.94 $ 28.460  Millions$ 3.185  Millions
Inspire Medical Systems inc   8.90 $ 569.809  Millions$ 63.989  Millions
Biodesix Inc   8.87 $ 44.026  Millions$ 4.966  Millions
Sanara Medtech Inc   8.83 $ 61.677  Millions$ 6.987  Millions
Insmed Inc  8.76 $ 277.639  Millions$ 31.691  Millions
Arrowhead Pharmaceuticals Inc   8.73 $ 240.735  Millions$ 27.562  Millions
Arcturus Therapeutics Holdings Inc   8.70 $ 296.237  Millions$ 34.067  Millions
Immucell Corp  8.69 $ 15.668  Millions$ 1.803  Millions
Addus Homecare Corporation  8.64 $ 1,028.360  Millions$ 119.077  Millions
Adapthealth Corp   8.62 $ 3,122.226  Millions$ 362.205  Millions

Date modified: 2023-11-12T04:48:51+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com